Enzinger Andrea C, Zhang Baohui, Schrag Deborah, Prigerson Holly G
Andrea C. Enzinger and Deborah Schrag, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Baohui Zhang and Holly G. Prigerson, Weill Cornell Medical College, New York, NY.
J Clin Oncol. 2015 Nov 10;33(32):3809-16. doi: 10.1200/JCO.2015.61.9239. Epub 2015 Oct 5.
To determine how prognostic conversations influence perceptions of life expectancy (LE), distress, and the patient-physician relationship among patients with advanced cancer.
This was a multicenter observational study of 590 patients with metastatic solid malignancies with progressive disease after ≥ one line of palliative chemotherapy, undergoing follow-up to death. At baseline, patients were asked whether their oncologist had disclosed an estimate of prognosis. Patients also estimated their own LE and completed assessments of the patient-physician relationship, distress, advance directives, and end-of-life care preferences.
Among this cohort of 590 patients with advanced cancer (median survival, 5.4 months), 71% wanted to be told their LE, but only 17.6% recalled a prognostic disclosure by their physician. Among the 299 (51%) of 590 patients willing to estimate their LE, those who recalled prognostic disclosure offered more realistic estimates as compared with patients who did not (median, 12 months; interquartile range, 6 to 36 months v 48 months; interquartile range, 12 to 180 months; P < .001), and their estimates were less likely to differ from their actual survival by > 2 (30.2% v 49.2%; odds ratio [OR], 0.45; 95% CI, 0.14 to 0.82) or 5 years (9.5% v 35.5%; OR, 0.19; 95% CI, 0.08 to 0.47). In adjusted analyses, recall of prognostic disclosure was associated with a 17.2-month decrease (95% CI, 6.2 to 28.2 months) in patients' LE self-estimates. Longer LE self-estimates were associated with lower likelihood of do-not-resuscitate order (adjusted OR, 0.439; 95% CI, 0.296 to 0.630 per 12-month increase in estimate) and preference for life-prolonging over comfort-oriented care (adjusted OR, 1.493; 95% CI, 1.091 to 1.939). Prognostic disclosure was not associated with worse patient-physician relationship ratings, sadness, or anxiety in adjusted analyses.
Prognostic disclosures are associated with more realistic patient expectations of LE, without decrements to their emotional well-being or the patient-physician relationship.
确定预后沟通如何影响晚期癌症患者对预期寿命(LE)的认知、痛苦程度以及医患关系。
这是一项多中心观察性研究,纳入了590例转移性实体恶性肿瘤患者,这些患者在接受≥一线姑息化疗后疾病仍进展,正在接受随访直至死亡。在基线时,询问患者其肿瘤医生是否告知过预后估计。患者还估计了自己的预期寿命,并完成了对医患关系、痛苦程度、预先医疗指示以及临终护理偏好的评估。
在这590例晚期癌症患者队列(中位生存期为5.4个月)中,71%的患者希望被告知其预期寿命,但只有17.6%的患者回忆起医生告知过预后。在590例愿意估计自己预期寿命的患者中,299例(51%)回忆起预后告知的患者给出的估计比未回忆起的患者更现实(中位数为12个月;四分位间距为6至36个月对48个月;四分位间距为12至180个月;P <.001),并且他们的估计与实际生存期相差>2年(30.2%对49.2%;比值比[OR]为0.45;95%置信区间为0.14至0.82)或5年(9.5%对35.5%;OR为0.19;95%置信区间为0.08至0.47)的可能性更小。在多因素分析中,回忆起预后告知与患者预期寿命自我估计减少17.2个月(95%置信区间为6.2至28.2个月)相关。预期寿命自我估计较长与下达不进行心肺复苏医嘱的可能性较低(多因素OR为0.439;每增加12个月的估计,95%置信区间为0.296至0.630)以及相较于以舒适为导向的护理更倾向于延长生命的护理(多因素OR为1.493;95%置信区间为1.091至1.939)相关。在多因素分析中,预后告知与较差的医患关系评分、悲伤或焦虑无关。
预后告知与患者对预期寿命更现实的期望相关,且不会降低他们的情绪幸福感或医患关系。